Abstract
References
Articles referenced by this article (19)
Hepatic tumors and cysts
1998
Experiments on the cause of the rabbit carcinomas derived from virus-induced papillomas. II. Loss by the Vx2 carcinoma of the power to immunize hosts against the papilloma virus.
J Exp Med, (2):159-174 1952
MED: 14955572
Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring: an experimental study on the VX2 tumor in the rabbit liver.
Cancer Res, (8):1863-1867 1996
MED: 8620505
Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis.
J Vasc Interv Radiol, (10):1245-1255 2000
MED: 11099235
Transcatheter chemo-embolization effective for treating hepatocellular carcinoma. A histopathologic study.
Cancer, (3):387-392 1984
MED: 6329503
Chemoembolization of hepatic malignancies.
Oncology (Williston Park), (4):77-84; discussion 84, 89-90 passim 1994
MED: 8003400
Glycolysis, respiration, and anomalous gene expression in experimental hepatomas: G.H.A. Clowes memorial lecture.
Cancer Res, (10):2007-2016 1972
MED: 4343003
Tumor mitochondria and the bioenergetics of cancer cells.
Prog Exp Tumor Res, 190-274 1978
MED: 149996
Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding.
J Biol Chem, (16):8699-8704 1981
MED: 7263678
Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location.
J Biol Chem, (18):10904-10912 1983
MED: 6885806
Show 9 more references (10 of 19)
Citations & impact
Impact metrics
Article citations
Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly.
World J Gastroenterol, 29(29):4499-4527, 01 Aug 2023
Cited by: 1 article | PMID: 37621758 | PMCID: PMC10445009
Review Free full text in Europe PMC
Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options.
Curr Oncol, 30(7):6609-6622, 10 Jul 2023
Cited by: 3 articles | PMID: 37504345 | PMCID: PMC10377758
Review Free full text in Europe PMC
Hypoxia-induced reprogramming of glucose-dependent metabolic pathways maintains the stemness of human bone marrow-derived endothelial progenitor cells.
Sci Rep, 13(1):8776, 31 May 2023
Cited by: 0 articles | PMID: 37258701 | PMCID: PMC10232473
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
Int J Mol Sci, 24(6):5493, 13 Mar 2023
Cited by: 5 articles | PMID: 36982568 | PMCID: PMC10052731
Review Free full text in Europe PMC
3-Bromopyruvate inhibits pancreatic tumor growth by stalling glycolysis, and dismantling mitochondria in a syngeneic mouse model.
Am J Cancer Res, 12(11):4977-4987, 15 Nov 2022
Cited by: 5 articles | PMID: 36504891 | PMCID: PMC9729896
Go to all (208) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
FDG-PET for evaluating the antitumor effect of intraarterial 3-bromopyruvate administration in a rabbit VX2 liver tumor model.
Korean J Radiol, 8(3):216-224, 01 May 2007
Cited by: 15 articles | PMID: 17554189 | PMCID: PMC2627418
The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate: in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model.
Korean J Radiol, 10(6):596-603, 01 Nov 2009
Cited by: 23 articles | PMID: 19885316 | PMCID: PMC2770822
Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma.
Mol Cancer Ther, 6(9):2554-2562, 01 Sep 2007
Cited by: 69 articles | PMID: 17876052
Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma.
Expert Rev Anticancer Ther, 4(3):449-457, 01 Jun 2004
Cited by: 86 articles | PMID: 15161443
Review